Medicure Inc. (MCUJF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:47PM EDT
| Previous Close | 0.7616 |
| Open | 0.8000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.8000 - 0.8000 |
| 52 Week Range | 0.6800 - 1.2600 |
| Volume | |
| Avg. Volume | 1,404 |
| Market Cap | 8.349M |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0700 |
| Earnings Date | May 24, 2024 - May 28, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREMedicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...
Simply Wall St.Medicure Full Year 2023 Earnings: CA$0.088 loss per share (vs CA$0.13 profit in FY 2022)
Medicure ( CVE:MPH ) Full Year 2023 Results Key Financial Results Revenue: CA$21.7m (down 5.9% from FY 2022). Net loss...
- ACCESSWIRE
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in ...
© 2024 Yahoo. All rights reserved.